![Catherine Kelly](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Catherine Kelly
Direttore Tecnico/Scientifico/R&S presso Perspectum Group Ltd.
Posizioni attive di Catherine Kelly
Società | Posizione | Inizio | Fine |
---|---|---|---|
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Direttore Tecnico/Scientifico/R&S | 01/05/2019 | - |
Storia della carriera di Catherine Kelly
Formazione di Catherine Kelly
University of York | Undergraduate Degree |
University of Oxford | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 4 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Settori
Consumer Services | 3 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Perspectum Group Ltd.
![]() Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
- Borsa valori
- Insiders
- Catherine Kelly
- Esperienza